See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Donald Trump
Baseball
Basketball
Republican Party
Elon Musk
Hockey
US Economy
US Politics
Vladimir Putin
Senate
Military
Immigration
Published • loading... • Updated

Amicus Therapeutics (NASDAQ:FOLD) Reports Fiscal Year 2024 Financial Results

Summary by themarketsdaily.com
Amicus Therapeutics, Inc. recently disclosed its financial results for the fiscal year ended December 31, 2024. The company issued a press release on February 19, 2025, detailing its performance. The total revenue for 2024 amounted to $528 million, reflecting a substantial growth of 33% (calculated at Constant Exchange Rates – CER) compared to the previous […]
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
themarketsdaily.comthemarketsdaily.com

Amicus Therapeutics (NASDAQ:FOLD) Reports Fiscal Year 2024 Financial Results

Amicus Therapeutics, Inc. recently disclosed its financial results for the fiscal year ended December 31, 2024. The company issued a press release on February 19, 2025, detailing its performance. The total revenue for 2024 amounted to $528 million, reflecting a substantial growth of 33% (calculated at Constant Exchange Rates – CER) compared to the previous […]

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

themarketsdaily.com broke the news in on Thursday, February 20, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

New Jersey

New Jersey

News
For You
Search
BlindspotLocal